CANBRIDGE-B (01228) released its annual performance, with a Shareholder attributable loss of 0.443 billion yuan, an increase of 16.84% year-on-year.

CANBRIDGE-B (01228) announced its annual results for the year ending December 31, 2024, with the group achieving revenues...

Zhitong FinanceMar 31 09:14 ET

Express News | CANbridge Pharmaceuticals FY Gross Margin 63.8%

ReutersMar 31 09:06 ET

Express News | CANbridge Pharmaceuticals FY Adjusted Net Income RMB -346.9 Million

ReutersMar 31 09:06 ET

Express News | CANbridge Pharmaceuticals FY Revenue RMB 85.1 Million

ReutersMar 31 09:06 ET

Express News | CANbridge Pharmaceuticals FY Gross Profit RMB 54.3 Million

ReutersMar 31 09:06 ET

CANBRIDGE-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024

HKEXMar 31 09:06 ET · Announcements